Subsequently, IHC experiments using samples from 70 osteosarcoma cases and 21 adjacent tissue samples confirmed differential expression of STC2 between cancer and normal tissues, and explored the gene’s expression in pan-cancer and its association with clinical pathological parameters of osteosarcoma. The gene discussed is STC2; the disease is osteosarcoma.